NCT06612242 Early vs. Late Tracheostomy in Patients With Guillain -Barre Syndrome
| NCT ID | NCT06612242 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Meir Medical Center |
| Condition | Guillain Barre Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-02-01 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2025-02-01 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Tracheostomy is one of the most common procedures in the intensive care unit in patients who need prolonged invasive mechanical ventilation. There is controversy in the literature regarding the ideal timing for performing tracheostomy in critically ill patients. Early tracheostomy may be associated with a decrease in ventilation days and hospitalization. We would like to investigate whether in ventilated patients with Guillain Barre syndrome, early tracheostomy will be associated with decreased ventilation days, decreased mortality and shorter hospital and ICU length of stay.
Eligibility Criteria
Inclusion Criteria: All patients aged 18--99 who were admitted to the general intensive care unit from January 2012 to September 2024 with a diagnosis of Guillain-Barre syndrome who required mechanical ventilation and underwent tracheostomy during ICU stay. \- Exclusion Criteria: Missing recoreded data \-
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06612242 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Guillain Barre Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06612242 currently recruiting?
Yes, NCT06612242 is actively recruiting participants. Contact the research team at sara.dichtwald@clalit.org.il for enrollment information.
Where is the NCT06612242 trial being conducted?
This trial is being conducted at Kfar Saba, Israel.
Who is sponsoring the NCT06612242 clinical trial?
NCT06612242 is sponsored by Meir Medical Center. The trial plans to enroll 30 participants.